Hirakata, Japan

Yoshikazu Goto

This inventor holds 49 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents, primarily in Information Recording. Top assignees: Matsushita Electric Industrial Co., Ltd., Ono Pharmaceutical Co., Ltd., Matsushita Electrical Industrial Co., Ltd.. Active years: 1992-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshikazu Goto. Retrieved from https://idiyas.com/inventor/yoshikazu-goto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 49 

% Patents Active = 95.9



Average Co-Inventor Count = 2.9

ph-index = 10

Forward Citations = 269(Granted Patents)


Location History:

  • Hirakatashi, JP (2001)
  • Hirakata, JP (1993 - 2008)
  • Osaka, JP (1992 - 2022)

Company Filing History:


Years Active: 1992-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Benzene Derivative
EP2 Agonist
Recording Medium
Disc Cartridge
Signal Recording
Information Reproducing
Disk Drive
Magnetic Disk
Optical Disk
Cartridge Adaptor
Clamping Device
Locking Mechanism
49 patents (USPTO):Explore Patents

Title: Yoshikazu Goto: Innovator in Neuroprotective Compounds

Introduction

Yoshikazu Goto, based in Hirakata, Japan, is a prolific inventor recognized for his substantial contributions to the field of medicinal chemistry. With 48 patents to his name, Goto's work primarily focuses on developing therapeutic agents aimed at treating various neurological and immune-related conditions.

Latest Patents

Among Goto's latest inventions are two significant patents. The first involves a benzene derivative that exhibits strong nerve-protecting and repairing properties. This compound, represented by a specific general formula, is poised for use in treating neuropathies such as chronic inflammatory demyelinating polyneuropathy and diabetic peripheral neuropathy. The second patent describes a compound with EP2 agonist activity, characterized as being highly safe. This innovative compound is intended for therapeutic applications linked to diseases associated with EP2 receptors, including immune disorders, allergic reactions, and various inflammatory conditions.

Career Highlights

Goto has notably worked with esteemed companies like Matsushita Electric Industrial Co., Ltd. and Ono Pharmaceutical Co., Ltd. His tenure at these organizations has greatly influenced his research and patent outputs, positioning him as a key figure in the drug development sector.

Collaborations

Throughout his career, Goto has collaborated with notable professionals such as Yukio Nishino and Kuniko Nakata. These partnerships have facilitated the advancement of innovative therapies and have contributed to the success of his patent filings.

Conclusion

Yoshikazu Goto's extensive patent portfolio and collaborative efforts highlight his significant role in advancing medical science, particularly in the development of treatments for neurological disorders. His dedication to innovation continues to inspire and impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…